Tris(cyclopentadienyl)yttrium | CAS:1294-07-1
Tris(cyclopentadienyl)yttrium
- Name：Tris(cyclopentadienyl)yttrium
- CAS：1294-07-1
- Synonyms：Tris(eta5-cyclopentadienyl)yttrium(III)
- Molecular Formula：C15H15Y
- Molecular Weight：284.19
- EINESC：215-069-4
Description
Properties
| 没有数据 | 没有数据 |
|---|
Safety
| 没有数据 | 没有数据 |
|---|
SDS
| Source | SDS/MSDS Samples |
|---|---|
| Alfa-Aesar | View & Download |
| Sigma-Aldrich | View & Download |
| Ereztech | View & Download |
Synthetic Route
| Name | CAS |
|---|
More
Articles
Peer-Reviewed Papers
Metal Exchange in the Interprotein ZnII -Binding Site of the Rad50 Hook Domain: Structural Insights into CdII -Induced DNA-Repair Inhibition.Michał Padjasek et al.Chemistry (Weinheim an der Bergstrasse, Germany), 26(15), 3297-3313 (2019-12-18)
Absolute Quantitation of Glycoforms of Two Human IgG Subclasses Using Synthetic Fc Peptides and Glycopeptides.Rini Roy et al.Journal of the American Society for Mass Spectrometry, 29(6), 1086-1098 (2018-05-26)
Design and synthesis of new N-(fluorenyl-9-methoxycarbonyl) (Fmoc)-dipeptides as anti-inflammatory agents.Chiao-Ting Yen et al.European journal of medicinal chemistry, 44(5), 1933-1940 (2008-12-27)
A New Caged-Glutamine Derivative as a Tool To Control the Assembly of Glutamine-Containing Amyloidogenic Peptides.Loay Awad et al.Chembiochem : a European journal of chemical biology, 17(24), 2353-2360 (2016-10-28)
Antibody Epitope of Human α-Galactosidase A Revealed by Affinity Mass Spectrometry: A Basis for Reversing Immunoreactivity in Enzyme Replacement Therapy of Fabry Disease.Zdenek Kukacka et al.ChemMedChem, 13(9), 909-915 (2018-02-24)
Protected Amino Acid-Based Hydrogels Incorporating Carbon Nanomaterials for Near-Infrared Irradiation-Triggered Drug Release.Chloé Guilbaud-Chéreau et al.ACS applied materials & interfaces, 11(14), 13147-13157 (2019-03-14)
Remarks
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
| Name | CAS |
|---|
Related Products
Related News
Question
Hot Tags
Inquiry
Fill in related informations ;please!
- Please fill in product name !
- CAS
- Please fill in your company information correctly!
- Please fill in liaison information correctly!
- Please fill in your telephone number correctly!
- Please fill in your email correctly!
- Please describe the problem of products!